BCAL Diagnostics (ASX:BDX) Market Cap : A$35.32 Mil (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BCAL Diagnostics's share price for the quarter that ended in Dec. 2023 was A$0.1. BCAL Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 251.64 Mil. Therefore, BCAL Diagnostics's market cap for the quarter that ended in Dec. 2023 was A$25.16 Mil.

BCAL Diagnostics's quarterly market cap increased from Dec. 2022 (A$12.69 Mil) to Jun. 2023 (A$14.86 Mil) and increased from Jun. 2023 (A$14.86 Mil) to Dec. 2023 (A$25.16 Mil).

BCAL Diagnostics's annual market cap increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$16.60 Mil) but then declined from Jun. 2022 (A$16.60 Mil) to Jun. 2023 (A$14.86 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BCAL Diagnostics's Enterprise Value for Today is A$31.81 Mil.

BCAL Diagnostics Market Cap Historical Data

The historical data trend for BCAL Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Market Cap Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Market Cap

16.60

14.86

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial			17.10	16.60	12.69	14.86	25.16

Competitive Comparison of BCAL Diagnostics's Market Cap

For the Diagnostics & Research subindustry, BCAL Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Market Cap falls into.

BCAL Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BCAL Diagnostics's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	A$0.07	*	212.315
	=	A$14.86

BCAL Diagnostics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	A$0.1	*	251.639
	=	A$25.16

BCAL Diagnostics (ASX:BDX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

BCAL Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.